Office of Research & Development |
![]() ![]() |
Project Number: | I01BX005051-01 |
Title: | Development of new therapies for cancer and other diseases and conditions using analogs of growth hormone-releasing hormones (GHRH) |
Principal Investigator: | Andrew V. Schally |
Location: | Miami, FL |
Congressional District Code: | 24 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | April 2020 - March 2024 |
FY 2021 Funding Amount: | $990,934 |
Total Award Amount (all years): |
$3,994,769 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: In view of documented activities and potential extensive applications of the antagonistic and agonistic analogs of growth hormone-releasing hormone (GHRH) in various areas of medicine, including the treatment of cancer, infarcted heart, diabetes, wounds and eye diseases, these projects will continue. Our main goal will be further development of analogs of GHRH, which appear to be free of side effects. Newly synthesized antagonists of growth hormone-releasing hormone (GHRH) of AVR class with high... |